The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Sickle cell disease (SCD) results in chronic hemolytic anemia, recurrent vascular occlusion,
insidious vital organ deterioration, early mortality, and diminished quality of life. Life …

Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

BACKGROUND Children with sickle cell disease (SCD) are at increased risk for
bloodstream infections (BSIs), mainly because of functional asplenia. Immunizations and …

Sickle cell disease (SCD) induces a chronic prothrombotic state. Central venous access
devices (CVADs) are commonly used for chronic transfusions and iron chelation in this …

Sickle cell disease (SCD)(sickle cell anaemia and related compound heterozygous states)
manifests as a hypercoagulable state with high levels of chronic platelet activation, thrombin …

Background Therapeutic apheresis has been used in treating hematological and non‐
hematological diseases. For a successful procedure, efficient vascular access is required …

Erythrocytapheresis (ER) can improve outcome in patients with sickle cell disease (SCD). A
good vascular access is required but frequently it can be difficult to obtain for sickle cell …

Background Apheresis treatments can be performed with peripheral venous catheters
(PVC), although central venous catheters (CVC) are inserted when PVCs fail or patient with …